Prosecution Insights
Last updated: April 19, 2026

Rohto Pharmaceutical Co. Ltd.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
3
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18695745 OPHTHALMOLOGICAL COMPOSITION VIGIL, TORIANA NICHOLE 1612 Non-Final OA Mar 26, 2024
18023119 COMPOSITION FOR AMELIORATING UNPLEASANT STATE CAUSED BY MENSTRUATION SASAN, ARADHANA 1615 Non-Final OA Feb 24, 2023
18018108 Aqueous Composition FAY, ZOHREH ALEMZADEH 1617 Final Rejection Jan 26, 2023
18018105 Aqueous Composition WELLES, COLMAN THOMAS 1612 Final Rejection Jan 26, 2023
17632419 Ophthalmic Composition for Promoting Tear Secretion HUANG, GIGI GEORGIANA 1613 Final Rejection Feb 02, 2022

Managing Rohto Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month